Relationships of indoleamine 2,3-dioxygenase activity and cofactors with asthma and nasal polyps

American Journal of Rhinology and Allergy

Volumn 28, Issue 1, 2014, Pages

  Luukkainen, Annika ^a   Karjalainen, Jussi ^b   Hurme, Mikko ^a,b   Paavonen, Timo ^a,b   Huhtala, Heini ^a   Toppila Salmi, Sanna ^c,d  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^d UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CORTICOSTEROID; ESSENTIAL AMINO ACID; INDOLEAMINE 2,3 DIOXYGENASE; TRYPTOPHAN; KYNURENINE;

ADULT; AGED; AIRWAY; AMINO ACID METABOLISM; ARTICLE; ASTHMA; ATOPY; BLOOD SAMPLING; CATABOLISM; CHRONIC RHINOSINUSITIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE DURATION; DRUG HYPERSENSITIVITY; ENVIRONMENTAL EXPOSURE; ENZYME ACTIVITY; EOSINOPHIL; FEMALE; FORCED EXPIRATORY VOLUME; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INFLAMMATION; LUNG FUNCTION; MAJOR CLINICAL STUDY; NOSE POLYP; RURAL AREA; SERUM; SMOKING; SYMPTOM; URBAN AREA; VERY ELDERLY; BLOOD; CHRONIC DISEASE; COHORT ANALYSIS; ENZYMOLOGY; FINLAND; IMMUNOLOGY; LIQUID CHROMATOGRAPHY; MALE; METABOLISM; MIDDLE AGED; RHINITIS; RURAL POPULATION; SINUSITIS;

ADULT; AGED; AGED, 80 AND OVER; ASTHMA; CHROMATOGRAPHY, LIQUID; CHRONIC DISEASE; COHORT STUDIES; EOSINOPHILS; FEMALE; FINLAND; HUMANS; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; KYNURENINE; MALE; MIDDLE AGED; NASAL POLYPS; RHINITIS; RURAL POPULATION; SINUSITIS; TRYPTOPHAN;

EID: 84893350403     PISSN: 19458924     EISSN: 19458932     Source Type: Journal    
DOI: 10.2500/ajra.2014.28.4013     Document Type: Article

References (57)

1. Braunstahl GJ. United airways concept: What does it teach us about systemic inflammation in airways disease? Proc Am Thorac Soc 6:652-654, 2009.
2. Brozek JL, Bousquet J, Baena-Cagnani CE, et al. Allergic Rhinitis and Its Impact on Asthma (ARIA) guidelines: 2010 Revision. J Allergy Clin Immunol 126:466-476, 2010.
3. Fokkens WJ, Lund VJ, Mullol J, et al. European position paper on rhinosinusitis and nasal polyps 2012. Rhinol Suppl 23:1-298, 2012.
4. Feng CH, Miller MD, and Simon RA. The united allergic airway: Connections between allergic rhinitis, asthma, and chronic sinusitis. Am J Rhinol Allergy 26:187-190, 2012.
5. Lin DC, Chandra RK, Tan BK, et al. Association between severity of asthma and degree of chronic rhinosinusitis. Am J Rhinol Allergy 25205-208, 2011.
6. Holgate ST. The airway epithelium is central to the pathogenesis of asthma. Allergol Int 57:1-10, 2008. (Pubitemid 351413241)
7. Agache I, Akdis C, Jutel M, and Virchow JC. Untangling asthma phenotypes and endotypes. Allergy 67:835-846, 2012.
8. To T, Stanojevic S, Moores G, Gershon AS, et al. Global asthma prevalence in adults: Findings from the cross-sectional world health survey. BMC Public Health. 12:204.
9. Hastan D, Fokkens WJ, Bachert C, et al. Chronic rhinosinusitis in Europe - An underestimated disease. A GA(2)LEN study. Allergy 66:1216-1223, 2011.
10. Hansel TT, Johnston SL, and Openshaw PJ. Microbes and mucosal immune responses in asthma. Lancet 381:861-873, 2013.
11. Ege MJ, Mayer M, Normand AC, et al. Exposure to environmental microorganisms and childhood asthma. N Engl J Med 364:701-709, 2011.
12. Hanski I, von Hertzen L, Fyhrquist N, et al. Environmental biodiversity, human microbiota, and allergy are interrelated. Proc Natl Acad Sci U S A 109:8334-8339, 2012.
13. Van Bruaene N, Perez-Novo CA, Basinski TM, et al. T-cell regulation in chronic paranasal sinus disease. J Allergy Clin Immunol 121:1435-1441, 1441.e1-3, 2008.
14. Jarvis D, Newson R, Lotvall J, et al. Asthma in adults and its association with chronic rhinosinusitis: The GA2LEN survey in Europe. Allergy 67:91-98, 2012.
15. Van Zele T, Claeys S, Gevaert P, et al. Differentiation of chronic sinus diseases by measurement of inflammatory mediators. Allergy 61:1280-1289, 2006. (Pubitemid 44465587)
16. Chang JE, White A, Simon RA, and Stevenson DD. Aspirin-exacerbated respiratory disease: Burden of disease. Allergy Asthma Proc 33:117-121, 2012.
17. Ebbens FA, Toppila-Salmi SK, Renkonen JA, et al. Endothelial L-selectin ligand expression in nasal polyps. Allergy 65:95-102, 2010.
18. Munn DH, Shafizadeh E, Attwood JT, et al. Inhibition of T cell proliferation by macrophage tryptophan catabolism. J Exp Med 189:1363-1372, 1999. (Pubitemid 29227522)
19. Mellor AL, Sivakumar J, Chandler P, et al. Prevention of T cell-driven complement activation and inflammation by tryptophan catabolism during pregnancy. Nat Immunol 2:64-68, 2001. (Pubitemid 33704955)
20. Mellor AL, Keskin DB, Johnson T, et al. Cells expressing indoleamine 2,3-dioxygenase inhibit T cell responses. J Immunol 168:3771-3776, 2002. (Pubitemid 34298376)
21. Belladonna ML, Orabona C, Grohmann U, and Puccetti P. TGF-beta and kynurenines as the key to infectious tolerance. Trends Mol Med 15:41-49, 2009.
22. Pallotta MT, Orabona C, Volpi C, et al. Indoleamine 2,3-dioxygenase is a signaling protein in long-term tolerance by dendritic cells. Nat Immunol 12:870-878, 2011.
23. Däubener W, and MacKenzie CR. IFN-gamma activated indoleamine 2,3-dioxygenase activity in human cells is an antiparasitic and an antibacterial effector mechanism. Adv Exp Med Biol 467:517-524, 1999. (Pubitemid 32202197)
24. Yuasa HJ, Takubo M, Takahashi A, et al. Evolution of vertebrate indoleamine 2,3-dioxygenases. J Mol Evol 65:705-714, 2007.
25. Maneechotesuwan K, Supawita S, Kasetsinsombat K, et al. Sputum indoleamine-2, 3-dioxygenase activity is increased in asthmatic airways by using inhaled corticosteroids. J Allergy Clin Immunol 121:43-50, 2008.
26. Raitala A, Karjalainen J, Oja SS, et al. Indoleamine 2,3-dioxygenase (IDO) activity is lower in atopic than in non-atopic individuals and is enhanced by environmental factors protecting from atopy. Mol Immunol 43:1054-1056, 2006. (Pubitemid 41814423)
27. Honkanen T, Luukkainen A, Lehtonen M, et al. Indoleamine 2,3-dioxygenase expression is associated with chronic rhinosinusitis with nasal polyps and antrochoanal polyps. Rhinology 49:356-363, 2011.
28. Luukkainen A, Karjalainen J, Honkanen T, et al. Indoleamine 2,3-dioxygenase expression in patients with allergic rhinitis: A casecontrol study. Clin Transl Allergy 1:17, 2011.
29. Karjalainen J, Hulkkonen J, Pessi T, et al. The IL1A genotype associates with atopy in nonasthmatic adults. J Allergy Clin Immunol 110:429-434, 2002.
30. Laich A, Neurauter G, Widner B, and Fuchs D. More rapid method for simultaneous measurement of tryptophan and kynurenine by HPLC. Clin Chem 48:579-581, 2002. (Pubitemid 34174597)
31. Han DH, Kim SW, Cho SH, et al. Predictors of bronchial hyperresponsiveness in chronic rhinosinusitis with nasal polyp. Allergy 64: 118-122, 2009.
32. Ahn Y, An SY, Won TB, et al. Nasal polyps: An independent risk factor for bronchial hyperresponsiveness in patients with allergic rhinitis. Am J Rhinol Allergy 24:359-363, 2010.
33. Vasilyeva ED, Kaledin V, Nikolin VP, et al. Accelerated rejection of the second transplants of immunogenic tumor in mice under inhibition of indoleamine 2,3-dioxygenase activity by ethyl pyruvate. Exp Oncol 34:66-68, 2012.
34. Outinen TK, Makela SM, Ala-Houhala IO, et al. High activity of indoleamine 2,3-dioxygenase is associated with renal insufficiency in puumala hantavirus induced nephropathia epidemica. J Med Virol 83:731-737, 2011.
35. Suzuki Y, Suda T, Asada K, et al. Serum indoleamine 2,3-dioxygenase activity predicts prognosis of pulmonary tuberculosis. Clin Vaccine Immunol 19:436-442, 2012.
36. Torres MI, López-Casado MA, Lorite P, Rios A. Tryptophan metabolism and indoleamine 2,3-dioxygenase expression in coeliac disease. Clin Exp Immunol 148:419-424, 2007. (Pubitemid 46701028)
37. Suzuki Y, Suda T, Yokomura K, et al. Serum activity of indoleamine 2,3-dioxygenase predicts prognosis of community-acquired pneumonia. J Infect 63:215-222, 2011.
38. Sekigawa T, Tajima A, Hasegawa T, et al. Gene-expression profiles in human nasal polyp tissues and identification of genetic susceptibility in aspirin-intolerant asthma. Clin Exp Allergy 39:972-981, 2009.
39. von Bubnoff D, and Bieber T. The indoleamine 2,3-dioxygenase (IDO) pathway controls allergy. Allergy 67:718-725, 2012.
40. Grohmann U, Volpi C, Fallarino F, et al. Reverse signaling through GITR ligand enables dexamethasone to activate IDO in allergy. Nat Med 13:579-586, 2007. (Pubitemid 46828479)
41. Swanson KA, Zheng Y, Heidler KM, et al. CDllc+ cells modulate pulmonary immune responses by production of indoleamine 2,3-dioxygenase. Am J Respir Cell Mol Biol 30:311-318, 2004. (Pubitemid 38315383)
42. Grohmann U, Bianchi R, Orabona C, et al. Functional plasticity of dendritic cell subsets as mediated by CD40 versus B7 activation. J Immunol 171:2581-2587, 2003. (Pubitemid 37025569)
43. Fallarino F, and Grohmann U. Indoleamine 2,3-dioxygenase: From catalyst to signaling function. Eur J Immunol 42:1932-1937, 2012.
44. Xu H, Oriss TB, Fei M, et al. Indoleamine 2,3-dioxygenase in lung dendritic cells promotes Th2 responses and allergic inflammation. Proc Natl Acad Sci U S A 105:6690-6695, 2008. (Pubitemid 351754568)
45. Xu H, Zhang GX, Ciric B, and Rostami A. IDO: A double-edged sword for T(H)1/T(H)2 regulation. Immunol Lett 121:1-6, 2008.
46. An XJ, Bai CX, Xia JB, et al. Immature dendritic cells expressing indoleamine 2,3-dioxygenase suppress ovalbumin-induced allergic airway inflammation in mice. J Investig Allergol Clin Immunol 21:185-192, 2011.
47. Hayashi T, Beck L, Rossetto C, et al. Inhibition of experimental asthma by indoleamine 2,3-dioxygenase. J Clin Invest 114:270-279, 2004. (Pubitemid 39071632)
48. Paveglio SA, Allard J, Foster Hodgkins SR, et al. Airway epithelial indoleamine 2,3-dioxygenase inhibits CD4+ T cells during aspergillus fumigatus antigen exposure. Am J Respir Cell Mol Biol 44:11-23, 2011.
49. von Bubnoff D, Fimmers R, Bogdanow M, et al. Asymptomatic atopy is associated with increased indoleamine 2,3-dioxygenase activity and interleukin-10 production during seasonal allergen exposure. Clin Exp Allergy 34:1056-1063, 2004. (Pubitemid 38969541)
50. Nakayama T, Yoshikawa M, Asaka D, et al. Mucosal eosinophilia and recurrence of nasal polyps - New classification of chronic rhinosinusitis. Rhinology 49:392-396, 2011.
51. Baraniuk JN, and Maibach H. Pathophysiological classification of chronic rhinosinusitis. Respir Res 6:149, 2005.
52. Hu Y, Cao PP, Liang GT, et al. Diagnostic significance of blood eosinophil count in eosinophilic chronic rhinosinusitis with nasal polyps in Chinese adults. Laryngoscope 122:498-503, 2012.
53. Woodruff PG, Modrek B, Choy DF, et al. T-helper type 2-driven inflammation defines major subphenotypes of asthma. Am J Respir Crit Care Med 180:388-395, 2009.
54. Schwartz N, Grossman A, Levy Y, and Schwarz Y. Correlation between eosinophil count and methacholine challenge test in asymptomatic subjects. J Asthma 49:336-341, 2012.
55. Visser MJ, Brand PL, Boezen HM, et al. Clinical and immunologic factors associated with the presence or absence of airways hyper-responsiveness in childhood asthma. Clin Exp Allergy 32:1278-1284, 2002. (Pubitemid 35024952)
56. Holmström M, Thelin A, Kolmodin-Hedman B, and Van Hage M. Nasal complaints and signs of disease in farmers - A methodological study. Acta Otolaryngol 128:193-200, 2008.
57. Eduard W, Douwes J, Omenaas E, and Heederik D. Do farming exposures cause or prevent asthma? Results from a study of adult Norwegian farmers. Thorax 59:381-386, 2004. (Pubitemid 38624743)